DIBBS #SPE2DP-27-T-0212

DLA request for two bottles of TEMBEXA (brincidofovir) oral suspension

DLA Troop Support is seeking two bottles of TEMBEXA (brincidofovir) for delivery to Walter Reed National Military Medical Center. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; contact: James Foggie. - OEM / approved source: Emergent Biodefense Operations Lans, identified with approved source part numbers NDC64678-0012-01 and NDC79622-0012-65. - Product: 2 bottles of brincidofovir 10 mg/mL oral suspension (TEMBEXA), NSN 6505-01-735-0149; unit of issue: bottle. - Requirements: FDA-regulated product; store at 20–25°C (68–77°F), protect from freezing, and discard unused contents 30 days after opening. - Delivery: FOB destination to Walter Reed National Military Medical Center, required 20 days after order.

Description

BRINCIDOFOVIR ORAL SUS (QTY: 2, NSN: 6505-01-735-0149, Purchase Request: 7018927942) Approved Sources: - CAGE: 1H0B6, Part No: NDC64678-0012-01, Company: EMERGENT BIODEFENSE OPERATIONS LANS - CAGE: 1H0B6, Part No: NDC79622-0012-65, Company: EMERGENT BIODEFENSE OPERATIONS LANS

View original listing